Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Italian Stock Exchange  >  DiaSorin SpA    DIA   IT0003492391

DIASORIN SPA (DIA)
Mes dernières consult.
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   End-of-day quote. End-of-day quote Italian Stock Exchange
06/18/2018 06/19/2018 06/20/2018 06/21/2018 06/22/2018 Date
92.3(c) 90.95(c) 89.5(c) 89.15(c) 96 Last
47 449 118 160 107 271 85 755 142 895 Volume
-0.75% -1.46% -1.59% -0.39% +7.68% Change
More quotes
Financials (EUR)
Sales 2018 697 M
EBIT 2018 212 M
Net income 2018 156 M
Finance 2018 180 M
Yield 2018 1,10%
Sales 2019 751 M
EBIT 2019 233 M
Net income 2019 169 M
Finance 2019 299 M
Yield 2019 1,21%
P/E ratio 2018 31,67
P/E ratio 2019 28,74
EV / Sales2018 6,93x
EV / Sales2019 6,27x
Capitalization 5 007 M
More Financials
Company
DiaSorin SpA engages in the development, production, and marketing of reagent kits for in vitro diagnostics.It specializes in the provision of immunodiagnostics and molecular diagnostics solutions which meet the needs of the following clinical areas: infectious diseases, cardiac markers, bone... 
More about the company
Surperformance© ratings of DiaSorin SpA
Trading Rating : Investor Rating :
More Ratings
Latest news on DIASORIN SPA
06/20DIASORIN : Kicks off Year-long Virtual Resource Center, Complete with Educationa..
AQ
06/12DIASORIN INTRODUCES PRIMER PAIR REAG : Anaplasma phagocytophilum, ehrlichia and ..
PU
06/08DIASORIN : Weekly report treasury shares buy-back
PU
06/04DIASORIN : Allegato 3F (acquisto azioni proprie maggio 2018)
PU
06/01DIASORIN : Weekly report treasury shares buy-back
PU
05/25DIASORIN : Weekly report treasury shares buy-back
PU
05/21DIASORIN SPA : Ex-dividend day for final dividend
FA
05/18DIASORIN : Weekly report treasury shares buy-back
PU
05/11DIASORIN : Weekly report treasury shares buy-back
PU
05/03DIASORIN : Start up treasury shares buy-back plan
PU
More news
Sector news : Diagnostic & Testing Substances
06/22LUXOTTICA : Italy's Luxottica buys sun lens maker Barberini for 140 million euro..
RE
06/15Essilor Calls General Meeting for EssilorLuxottica
DJ
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
More sector news : Diagnostic & Testing Substances
Latest Tweets
06/01DiaSorin : Weekly report treasury shares buy-back  
05/25DiaSorin : Weekly report treasury shares buy-back  
05/11DiaSorin : Weekly report treasury shares buy-back  
05/03DiaSorin : Start up treasury shares buy-back plan  
04/19DiaSorin : Weekly report treasury shares buy-back  
More tweets
Qtime:29
News from SeekingAlpha
03/08Diasorin SPA ADR 2017 Q4 - Results - Earnings Call Slides 
2017Diasorin SPA ADR 2017 Q3 - Results - Earnings Call Slides 
2017DiaSorin (DSRLF) Investor Presentation - Slideshow 
2016Winner And Losers Among Italian Companies 
2016Diasorin SPA ADR 2016 Q3 - Results - Earnings Call Slides 
Chart DIASORIN SPA
Duration : Period :
DiaSorin SpA Technical Analysis Chart | DIA | IT0003492391 | 4-Traders
Technical analysis trends DIASORIN SPA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Average target price 78,6 €
Spread / Average Target -12%
EPS Revisions
Managers
NameTitle
Carlo Rosa Chief Executive Officer, Executive Director & GM
Gustavo Denegri Chairman
Piergiorgio Pedron Chief Financial Officer & Senior Corporate VP
Chen Menachem Even Executive Director & Chief Commercial Officer
Franco Moscetti Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DIASORIN SPA20.95%5 823
BIOMÉRIEUX2.02%10 598
AUTOBIO DIAGNOSTICS CO LTD48.40%5 103
MACCURA BIOTECHNOLOGY CO LTD--.--%2 095
SIEGFRIED HOLDING AG21.91%1 691
GETEIN BIOTECH INC24.10%1 561